VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients
Clinical trial NCT03671850 · UNKNOWN
Trial details
- NCT number
- NCT03671850
- Sponsor
- ViGenCell Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2023-12-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.